Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines
Susanne Oertel(Heidelberger Institut für Radioonkologie), Claudia Blattmann(Olgahospital)
Cited by 15
Related Papers
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
|European Journal of Cancer|2021|34
Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis
|Journal of Adolescent and Young Adult Oncology|2022|3